よむ、つかう、まなぶ。
05資料2-1森野委員提出資料（RSウイルス母子免疫ワクチンと抗体製剤ファクトシート） (46 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64997.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第32回 10／22）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
49.
国立感染症研究所感染症疫学センター. 感染症発生動向調査からみる 2018 年～2021 年の我が国の
RS ウイルス感染症の状況. 2022.
50.
Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute
lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a
systematic analysis. Lancet 2022; 399(10340): 2047-64.
51.
Wildenbeest JG, Billard MN, Zuurbier RP, et al. The burden of respiratory syncytial virus in
healthy term-born infants in Europe: a prospective birth cohort study. Lancet Respir Med 2023; 11(4):
341-53.
52.
Brunwasser SM, Snyder BM, Driscoll AJ, et al. Assessing the strength of evidence for a causal
effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a
systematic review and meta-analysis. Lancet Respir Med 2020; 8(8): 795-806.
53.
Feikin DR, Karron RA, Saha SK, et al. The full value of immunisation against respiratory
syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness.
Lancet Infect Dis 2024; 24(5): e318-e27.
54.
Arashiro T, Kramer R, Jin J, Kano M, Wang F, Miyairi I. Inpatient Burden of Respiratory
Syncytial Virus Infection and Influenza in Children Younger Than 5 Years in Japan, 2011-2022: A
Database Study. Influenza Other Respir Viruses 2024; 18(11): e70045.
55.
Kobayashi Y, Togo K, Agosti Y, McLaughlin JM. Epidemiology of respiratory syncytial virus in
Japan: A nationwide claims database analysis. Pediatr Int 2022; 64(1): e14957.
56.
Okubo Y, Uda K, Yoshikawa Y, Ogimi C, Nakabayashi Y, Ito K. Nationwide Epidemiology and
Outpatient Healthcare Resource Use of Children with Respiratory Syncytial Virus from 2005 to 2021. J
Pediatric Infect Dis Soc 2025; 14(1).
57.
Simões EAF, Botteman M, Chirikov V. Epidemiology of Medically Attended Respiratory
Syncytial Virus Lower Respiratory Tract Infection in Japanese Children, 2011-2017. J Infect Dis 2024;
229(4): 1112-22.
58.
Okubo Y, Uda K, Ogimi C, Shimabukuro R, Ito K. Clinical Practice Patterns and Risk Factors
for Severe Conditions in Pediatric Hospitalizations With Respiratory Syncytial Virus in Japan: A
Nationwide Analyses (2018-2022). Pediatr Infect Dis J 2024; 43(3): 187-93.
59.
Otsuka M, Kasamatsu A, Arima Y, et al. Respiratory Syncytial Virus Infection Notification
Trends and Interpretation of the Reported Case Data, 2018-2021, Japan. Jpn J Infect Dis 2025; 78(1): 514.
60.
厚生労働省. 人口動態調査 人口動態統計 確定数 死亡. 2024/09/17 2023. https://www.e-
stat.go.jp/dbview?sid=0003411673 (accessed 2025/6/2).
61.
World Health Organization. Weekly epidemiological record - Meeting of the Strategic Advisory
Group of Experts on Immunization, September 2024: conclusions and recommendations - Respiratory
syncytial virus. 2024. https://iris.who.int/bitstream/handle/10665/379717/WER9949-eng-fre.pdf (accessed
2025/04/28).
62.
World Health Organization. WHO position paper on immunization to protect infants against
46
国立感染症研究所感染症疫学センター. 感染症発生動向調査からみる 2018 年～2021 年の我が国の
RS ウイルス感染症の状況. 2022.
50.
Li Y, Wang X, Blau DM, et al. Global, regional, and national disease burden estimates of acute
lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a
systematic analysis. Lancet 2022; 399(10340): 2047-64.
51.
Wildenbeest JG, Billard MN, Zuurbier RP, et al. The burden of respiratory syncytial virus in
healthy term-born infants in Europe: a prospective birth cohort study. Lancet Respir Med 2023; 11(4):
341-53.
52.
Brunwasser SM, Snyder BM, Driscoll AJ, et al. Assessing the strength of evidence for a causal
effect of respiratory syncytial virus lower respiratory tract infections on subsequent wheezing illness: a
systematic review and meta-analysis. Lancet Respir Med 2020; 8(8): 795-806.
53.
Feikin DR, Karron RA, Saha SK, et al. The full value of immunisation against respiratory
syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness.
Lancet Infect Dis 2024; 24(5): e318-e27.
54.
Arashiro T, Kramer R, Jin J, Kano M, Wang F, Miyairi I. Inpatient Burden of Respiratory
Syncytial Virus Infection and Influenza in Children Younger Than 5 Years in Japan, 2011-2022: A
Database Study. Influenza Other Respir Viruses 2024; 18(11): e70045.
55.
Kobayashi Y, Togo K, Agosti Y, McLaughlin JM. Epidemiology of respiratory syncytial virus in
Japan: A nationwide claims database analysis. Pediatr Int 2022; 64(1): e14957.
56.
Okubo Y, Uda K, Yoshikawa Y, Ogimi C, Nakabayashi Y, Ito K. Nationwide Epidemiology and
Outpatient Healthcare Resource Use of Children with Respiratory Syncytial Virus from 2005 to 2021. J
Pediatric Infect Dis Soc 2025; 14(1).
57.
Simões EAF, Botteman M, Chirikov V. Epidemiology of Medically Attended Respiratory
Syncytial Virus Lower Respiratory Tract Infection in Japanese Children, 2011-2017. J Infect Dis 2024;
229(4): 1112-22.
58.
Okubo Y, Uda K, Ogimi C, Shimabukuro R, Ito K. Clinical Practice Patterns and Risk Factors
for Severe Conditions in Pediatric Hospitalizations With Respiratory Syncytial Virus in Japan: A
Nationwide Analyses (2018-2022). Pediatr Infect Dis J 2024; 43(3): 187-93.
59.
Otsuka M, Kasamatsu A, Arima Y, et al. Respiratory Syncytial Virus Infection Notification
Trends and Interpretation of the Reported Case Data, 2018-2021, Japan. Jpn J Infect Dis 2025; 78(1): 514.
60.
厚生労働省. 人口動態調査 人口動態統計 確定数 死亡. 2024/09/17 2023. https://www.e-
stat.go.jp/dbview?sid=0003411673 (accessed 2025/6/2).
61.
World Health Organization. Weekly epidemiological record - Meeting of the Strategic Advisory
Group of Experts on Immunization, September 2024: conclusions and recommendations - Respiratory
syncytial virus. 2024. https://iris.who.int/bitstream/handle/10665/379717/WER9949-eng-fre.pdf (accessed
2025/04/28).
62.
World Health Organization. WHO position paper on immunization to protect infants against
46